Genetic & Cystic
Inherited and cystic kidney diseases — ADPKD, Alport syndrome, Fabry disease, and novel therapies, curated by ASNRT.
Browse all news
Explore the full ASNRT newsroom for society announcements, KDIGO guideline updates, AJNT issue releases, and notable developments across the breadth of nephrology.
Latest in this topic
The most recent evidence summaries curated by ASNRT on this topic:
The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care · KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): executive summary · Alport syndrome: an update. · Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease · Treatment of Autosomal-Dominant Polycystic Kidney Disease. · Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. · Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease